Abstract Search

ea0038p118 | Clinical practice/governance and case reports | SFEBES2015

Management of patients with adrenal insufficiency attending Galway University Hospital compared with current best practice

Cormican Sarah , Casey Ruth , O'Shea Paula , Bell Marcia

Introduction: Patients with adrenal insufficiency (AI) lack endogenous cortisol and require oral hydrocortisone. In primary AI (PAI) endogenous aldosterone synthesis is also lost and patients require oral fludrocortisone. Important long-term issues include wearing MedicAlert jewellery (MAJ) and adequacy of steroid replacement including fludrocortisone, assessed by plasmarenin activity (PRA).We identified patients with AI attending our unit and aime...

0 shares

ePoster Contact

ea0023oc2.1 | Oral Communications 2 | BSPED2009

Final height in Turner syndrome after Oxandrolone and delayed pubertal induction: results of a UK randomised, double-blind, placebo-controlled trial

Gault Emma-Jane , Perry Rebecca , Casey Sarah , Cole Tim , Paterson Wendy , Hindmarsh Peter , Betts Peter , Dunger David , Donaldson Malcolm

The UK Turner Study examined in girls with Turner syndrome (TS) the impact on final height (FH) of Oxandrolone (Ox) and/or delayed pubertal induction (14y).Methods: Girls with TS aged 713y receiving GH were randomised to Ox (0.05 mg/kg per day, max. dose 2.5 mg/day) or placebo from 9y (or from enrolment if >9y). Girls requiring oestrogen were further randomised to begin oral Ethinylestradiol (E2) (Y1:2 μg/day; Y2:4 μg/day; ...

0 shares

Endocrine Abstracts

Management of patients with adrenal insufficiency attending Galway University Hospital compared with current best practice

Final height in Turner syndrome after Oxandrolone and delayed pubertal induction: results of a UK randomised, double-blind, placebo-controlled trial

BiosciAbstracts